Percutaneous Transluminal Coronary Angioplasty versus Coronary Artery Bypass: Isn't It Time for a Randomized Trial?

Michael B. Mock; Guy S. Reeder; Hartzell V. Schaff; David R. Holmes; Ronald E. Vlietstra; Hugh C. Smith; Bernard J. Gersh

doi:10.1056/NEJM198504043121410

Percutaneous Transluminal Coronary Angioplasty versus Coronary Artery Bypass: Isn't It Time for a Randomized Trial?

Michael B. Mock, Guy S. Reeder, Hartzell V. Schaff, David R. Holmes, Ronald E. Vlietstra, Hugh C. Smith, Bernard J. Gersh

Research output: Contribution to journal › Editorial › peer-review

23 Scopus citations

Abstract

Ischemic heart disease continues to be the major cause of disability and death in the United States. Despite the availability of effective medications, each year a large number of patients undergo revascularization. In 1983, 191,000 coronary artery bypass operations were reported to the National Hospital Discharge Survey of the National Center for Health Care Statistics. Three multicenter randomized trials comparing medical treatment with coronary artery bypass have shown that bypass surgery significantly relieves symptoms and improves functional capacity but has a smaller effect in terms of prolonging life and little, if any, effect in preventing myocardial infarction.¹ ² ³ ⁴ An improvement in.

Original language	English (US)
Pages (from-to)	916-919
Number of pages	4
Journal	New England Journal of Medicine
Volume	312
Issue number	14
DOIs	https://doi.org/10.1056/NEJM198504043121410
State	Published - Apr 4 1985

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJM198504043121410

Cite this

@article{bf250798c4b24e6fa5b1f5fbd89d21b9,

title = "Percutaneous Transluminal Coronary Angioplasty versus Coronary Artery Bypass: Isn't It Time for a Randomized Trial?",

abstract = "Ischemic heart disease continues to be the major cause of disability and death in the United States. Despite the availability of effective medications, each year a large number of patients undergo revascularization. In 1983, 191,000 coronary artery bypass operations were reported to the National Hospital Discharge Survey of the National Center for Health Care Statistics. Three multicenter randomized trials comparing medical treatment with coronary artery bypass have shown that bypass surgery significantly relieves symptoms and improves functional capacity but has a smaller effect in terms of prolonging life and little, if any, effect in preventing myocardial infarction.1 2 3 4 An improvement in.",

author = "Mock, {Michael B.} and Reeder, {Guy S.} and Schaff, {Hartzell V.} and Holmes, {David R.} and Vlietstra, {Ronald E.} and Smith, {Hugh C.} and Gersh, {Bernard J.}",

year = "1985",

month = apr,

day = "4",

doi = "10.1056/NEJM198504043121410",

language = "English (US)",

volume = "312",

pages = "916--919",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "14",

}

TY - JOUR

T1 - Percutaneous Transluminal Coronary Angioplasty versus Coronary Artery Bypass

T2 - Isn't It Time for a Randomized Trial?

AU - Mock, Michael B.

AU - Reeder, Guy S.

AU - Schaff, Hartzell V.

AU - Holmes, David R.

AU - Vlietstra, Ronald E.

AU - Smith, Hugh C.

AU - Gersh, Bernard J.

PY - 1985/4/4

Y1 - 1985/4/4

N2 - Ischemic heart disease continues to be the major cause of disability and death in the United States. Despite the availability of effective medications, each year a large number of patients undergo revascularization. In 1983, 191,000 coronary artery bypass operations were reported to the National Hospital Discharge Survey of the National Center for Health Care Statistics. Three multicenter randomized trials comparing medical treatment with coronary artery bypass have shown that bypass surgery significantly relieves symptoms and improves functional capacity but has a smaller effect in terms of prolonging life and little, if any, effect in preventing myocardial infarction.1 2 3 4 An improvement in.

AB - Ischemic heart disease continues to be the major cause of disability and death in the United States. Despite the availability of effective medications, each year a large number of patients undergo revascularization. In 1983, 191,000 coronary artery bypass operations were reported to the National Hospital Discharge Survey of the National Center for Health Care Statistics. Three multicenter randomized trials comparing medical treatment with coronary artery bypass have shown that bypass surgery significantly relieves symptoms and improves functional capacity but has a smaller effect in terms of prolonging life and little, if any, effect in preventing myocardial infarction.1 2 3 4 An improvement in.

UR - http://www.scopus.com/inward/record.url?scp=0022002658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022002658&partnerID=8YFLogxK

U2 - 10.1056/NEJM198504043121410

DO - 10.1056/NEJM198504043121410

M3 - Editorial

C2 - 3156275

AN - SCOPUS:0022002658

SN - 0028-4793

VL - 312

SP - 916

EP - 919

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 14

ER -

Percutaneous Transluminal Coronary Angioplasty versus Coronary Artery Bypass: Isn't It Time for a Randomized Trial?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this